A total of 111 patients with complete MRI imaging data and complete results of MGMT promoter methylation status were enrolled in the training (89 patients) and validation cohorts (22 patients), including 56 patients with MGMT methylated gliomas and 55 patients with MGMT unmethylated gliomas. The gene discussed is MGMT; the disease is glioma.